Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Femoral hypoplasia - unusual facies syndrome

Known as: Femoral hypoplasia unusual facies syndrome, Femoral-Facial Syndrome, FHUFS 
 
National Institutes of Health

Related topics

Related topics

20 relations
Cleft PalateCongenital clubfootCryptorchidismEsotropia
Expand

Broader (2)

FemurPierre Robin Syndrome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
The Five-Factor Score Revisited: Assessment of Prognoses of Systemic Necrotizing Vasculitides Based on the French Vasculitis Study Group (FVSG) Cohort
The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis nodosa [PAN], microscopic polyangiitis [MPA… Expand
Is this relevant?
Review
2010
Review
2010
Congenital hypothyroidism
Congenital hypothyroidism (CH) occurs in approximately 1:2,000 to 1:4,000 newborns. The clinical manifestations are often subtle… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
FOOT STRIKE PATTERNS OF RUNNERS AT THE 15‐KM POINT DURING AN ELITE‐LEVEL HALF MARATHON
There are various recommendations by many coaches regarding foot landing techniques in distance running that are meant to improve… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
PURPOSE To address early and late treatment failures in older patients with diffuse large B-cell lymphoma (DLBCL), we designed a… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine…
PURPOSE To determine the response, failure-free survival (FFS), and overall survival rates and toxicity of rituximab plus an… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
PURPOSE The study goal was to improve outcome in children with rhabdomyosarcoma by comparing risk-based regimens of surgery… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
OBJECTIVE To determine the long-term outcome of patients with polyarteritis nodosa (PAN), microscopic polyangiitis (MPA), and… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
We undertook this study to determine the clinical, biologic, immunologic, and therapeutic factors associated with the prognoses… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
An Implementation of a Log-Structured File System for UNIX
Research results [ROSE91] suggest that a log-structured file system (LFS) offers the potential for dramatically improved write… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1966
Highly Cited
1966
Hydrochemical facies and ground-water flow patterns in northern part of Atlantic Coastal Plain
-----------~-----------------------------A 1 Hydrochemical facies-Continued In troduction ______________________________________… Expand
  • figure 2
  • figure 4
  • table 2
  • figure 5
  • figure 6
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE